Investing.com -- KKR (NYSE:KKR) has agreed to sell a "substantial minority" stake in Viridor Group to Equitix, according to a statement released Monday. The transaction terms were not disclosed.
MOSCOW, Dec 22 (Reuters) - The Kremlin said on Monday that if U.S. intelligence believed that Russian President Vladimir Putin wanted to capture all of Ukraine and reclaim parts of Europe that were ...
Investing.com -- Mobile Streams plc plans to acquire the remaining 75.2% stake in Estadio Gana and 77.5% of Capital Media Sports as part of a reverse takeover deal, while raising £3.02 million and ...
Investing.com -- The Italian Competition Authority has imposed a fine of €98.6 million ($115.5 million) on Apple Inc., Apple Distribution International Ltd., and Apple Italia Srl for abusing their ...
Shares of Nvidia (NASDAQ:NVDA) rose roughly 4% as sentiment improved on reports that the Trump administration is reviewing allowing sales of advanced AI chips to China for approved customers, helping ...
Investing.com -- The Rank Group Plc (LSE:RNK) announced Monday that its Spanish businesses, Enracha and Yo, have been victims of a payment fraud totaling approximately €7.1 million.
COPENHAGEN, Dec 22 (Reuters) - U.S. President Donald Trump’s decision to appoint Louisiana Governor Jeff Landry as a special envoy to Greenland signals sustained American interest in the Arctic island ...
Investing.com -- Harbour Energy PLC (LON:HBR) announced Monday it has entered into an agreement to acquire LLOG Exploration Company LLC for $3.2 billion, marking its strategic entry into the deepwater ...
Investing.com -- Coty Inc (NYSE:COTY) has appointed Markus Strobel as executive chairman and interim chief executive officer, the beauty company announced Monday. Strobel will take over the roles ...
MILAN, Dec 22 (Reuters) - Italy’s competition authority said on Monday it had fined U.S tech giant Apple and two of its units 98.6 million euros ($115.53 million) over alleged abuse of dominant ...
Investing.com -- AstraZeneca PLC (NASDAQ:AZN) announced Monday that its LATIFY Phase III trial of ceralasertib failed to meet its primary endpoint in non-small cell lung cancer (NSCLC).
S&P 500, SPDR® S&P 500® ETF Trust, US Dollar Index Futures, Gold Futures. Read 's Market Analysis on Investing.com ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results